Abstract |
Gliptins are well recognized substances modulating incretin system via inhibition of dipeptidylpeptidase IV. Their efficacy was demonstrated both in monotherapy and in combination with metformin, where they act synergistically. Hence, a better control of diabetes might be assumed. This short article aims to show current trends in their prescription in the Czech Republic.Key words: diabetes mellitus - dipeptidylpeptidase IV - gliptins - oral antidiabetics.
|
Authors | Jiří Slíva, Martin Prázný |
Journal | Vnitrni lekarstvi
(Vnitr Lek)
Vol. 60
Issue 9
Pg. 772-4
(Sep 2014)
ISSN: 0042-773X [Print] Czech Republic |
Vernacular Title | Gliptiny: bezpečná a účinná léčba diabetu. |
PMID | 25294767
(Publication Type: English Abstract, Journal Article)
|